Trials / Completed
CompletedNCT01399216
Effects of a Supplement Containing Fucoidan on Basal Body Temperature
Effects of a Supplement Containing Fucoidan as a Major Component on Basal Body Temperature: a Placebo Controlled, Cross-over Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 19 (actual)
- Sponsor
- Hiroshima University · Academic / Other
- Sex
- Female
- Age
- 55 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
We aim to determine whether a supplement containing fucoidan isolated from Mekabu (sporophyll of Undaria pinnatifida), EPA, and DHA has effects of elevating basal body temperature in subjects with low basal body temperature.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Supplement containing fucoidan, EPA, and DHA | 75 mg fucoidan per day, for 8 weeks |
| DIETARY_SUPPLEMENT | Placebo | for 8 weeks |
Timeline
- Start date
- 2011-07-01
- Primary completion
- 2012-03-01
- Completion
- 2012-03-01
- First posted
- 2011-07-21
- Last updated
- 2012-12-17
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01399216. Inclusion in this directory is not an endorsement.